ClariVest Asset Management LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 216 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
ClariVest Asset Management LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$587,000
-24.2%
8,618
-22.8%
0.02%
-25.9%
Q1 2021$774,000
-78.4%
11,168
-76.1%
0.03%
-77.9%
Q4 2020$3,591,000
-23.9%
46,768
-25.9%
0.12%
-21.3%
Q3 2020$4,720,000
+15.0%
63,131
-3.1%
0.16%
+38.4%
Q2 2020$4,104,000
+40.7%
65,179
-6.1%
0.11%
+28.7%
Q1 2020$2,916,000
-5.2%
69,447
+2.6%
0.09%
+22.5%
Q4 2019$3,075,000
-27.5%
67,690
-27.0%
0.07%
-25.3%
Q3 2019$4,243,000
-22.8%
92,739
-1.1%
0.10%
-23.4%
Q2 2019$5,497,000
+98.4%
93,739
+51.6%
0.12%
+121.4%
Q1 2019$2,771,000
-26.7%
61,839
-36.2%
0.06%
-30.9%
Q4 2018$3,778,000
-2.5%
96,981
+15.2%
0.08%
+17.4%
Q3 2018$3,874,000
-1.5%
84,195
-6.7%
0.07%
+1.5%
Q2 2018$3,934,000
-16.3%
90,249
-24.2%
0.07%
-16.0%
Q1 2018$4,702,000
+71.1%
119,030
+47.2%
0.08%
+72.3%
Q4 2017$2,748,000
+27.5%
80,868
-4.4%
0.05%
-6.0%
Q3 2017$2,156,00084,5820.05%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Prosight Management, LP 164,300$9,633,0004.86%
Atika Capital Management LLC 230,000$13,485,0002.65%
DAFNA Capital Management LLC 93,942$5,508,0002.07%
PFM Health Sciences, LP 1,828,378$107,198,0002.04%
Perceptive Advisors 1,380,171$80,919,0001.86%
Eversept Partners, LP 73,501$4,309,3641.21%
Partner Investment Management, L.P. 18,159$1,065,0001.13%
Rhenman & Partners Asset Management AB 170,000$9,967,0001.10%
EMERALD ADVISERS, LLC 425,510$24,948,0001.00%
EMERALD MUTUAL FUND ADVISERS TRUST 388,418$22,773,0000.90%
View complete list of ARENA PHARMACEUTICALS INC shareholders